Alu-based cell-free DNA: A potential complementary biomarker for diagnosis of colorectal cancer

Clinical Biochemistry

Volumn 46, Issue 1-2, 2013, Pages 64-69

  Qi, Jing ^a   Qian, Chen ^a   Shi, Wei ^a   Wu, Xinhua ^a   Jing, Rongrong ^a   Zhang, Lurong ^b   Wang, Zhiwei ^a   Ju, Shaoqing ^a  

^a NANTONG UNIVERSITY   (China)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Alu; Biomarker; Branch DNA technology; Cell free DNA; Colorectal cancer

Indexed keywords

BRANCH DNA; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CELL FREE DNA; DNA; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ALU SEQUENCE; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; COLORECTAL CANCER; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; INTESTINE POLYP; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; ALU ELEMENTS; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; DNA; FEMALE; HUMANS; INTESTINAL POLYPS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES; ROC CURVE; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 84871816298     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2012.08.026     Document Type: Article

References (23)

1. Weitz J., Koch M., Debus J., Hohler T., Galle P.R., Buchler M.W. Colorectal cancer. Lancet 2005, 365:153-165.
2. Ogino S., Goel A. Molecular classification and correlates in colorectal cancer. J Mol Diagn 2008, 10:13-27.
3. Mutch M.G. Molecular profiling and risk stratification of adenocarcinoma of the colon. J Surg Oncol 2007, 96:693-703.
4. Ludwig J.A., Weinstein J.N. Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer 2005, 5:845-856.
5. Thierry A.R., Mouliere F., Gongora C., Ollier J., Robert B., Ychou M., et al. Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts. Nucleic Acids Res 2010, 38:6159-6175.
6. Garcia-Olmo D.C., Gutierrez-Gonzalez L., Ruiz-Piqueras R., Picazo M.G., Garcia-Olmo D. Detection of circulating tumor cells and of tumor DNA in plasma during tumor progression in rats. Cancer Lett 2005, 217:115-123.
7. Czeiger D., Shaked G., Eini H., Vered I., Belochitski O., Avriel A., et al. Measurement of circulating cell-free DNA levels by a new simple fluorescent test in patients with primary colorectal cancer. Am J Clin Pathol 2011, 135:264-270.
8. Sozzi G., Conte D., Mariani L., Lo Vullo S., Roz L., Lombardo C., et al. Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients. Cancer Res 2001, 61:4675-4678.
9. Jing R.R., Wang H.M., Cui M., Fang M.K., Qiu X.J., Wu X.H., et al. A sensitive method to quantify human cell-free circulating DNA in blood: relevance to myocardial infarction screening. Clin Biochem 2011, 44:1074-1079.
10. Mandel P., Metais P. [not available]. C R Seances Soc Biol Fil 1948, 142:241-243.
11. Tan E.M., Schur P.H., Carr R.I., Kunkel H.G. Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. J Clin Invest 1966, 45:1732-1740.
12. Leon S.A., Shapiro B., Sklaroff D.M., Yaros M.J. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 1977, 37:646-650.
13. Jung K., Fleischhacker M., Rabien A. Cell-free DNA in the blood as a solid tumor biomarker-a critical appraisal of the literature. Clin Chim Acta 2010, 411:1611-1624.
14. Chen H., Sun L.Y., Zheng H.Q., Zhang Q.F., Jin X.M. Total serum DNA and DNA integrity: diagnostic value in patients with hepatitis b virus-related hepatocellular carcinoma. Pathology 2012, 44:318-324.
15. Bastian P.J., Palapattu G.S., Yegnasubramanian S., Lin X., Rogers C.G., Mangold L.A., et al. Prognostic value of preoperative serum cell-free circulating DNA in men with prostate cancer undergoing radical prostatectomy. Clin Cancer Res 2007, 13:5361-5367.
16. Grover D., Mukerji M., Bhatnagar P., Kannan K., Brahmachari S.K. Alu repeat analysis in the complete human genome: trends and variations with respect to genomic composition. Bioinformatics 2004, 20:813-817.
17. Sirera R., Bremnes R.M., Cabrera A., Jantus-Lewintre E., Sanmartin E., Blasco A., et al. Circulating DNA is a useful prognostic factor in patients with advanced non-small cell lung cancer. J Thorac Oncol 2011, 6:286-290.
18. Herrera L.J., Raja S., Gooding W.E., El-Hefnawy T., Kelly L., Luketich J.D., et al. Quantitative analysis of circulating plasma DNA as a tumor marker in thoracic malignancies. Clin Chem 2005, 51:113-118.
19. Fleischhacker M., Schmidt B. Circulating nucleic acids (cnas) and cancer-a survey. Biochim Biophys Acta 2007, 1775:181-232.
20. Knudsen B.S., Allen A.N., McLerran D.F., Vessella R.L., Karademos J., Davies J.E., et al. Evaluation of the branched-chain DNA assay for measurement of rna in formalin-fixed tissues. J Mol Diagn 2008, 10:169-176.
21. Berrodin T.J., Jelinsky S.A., Graciani N., Butera J.A., Zhang Z., Nagpal S., et al. Novel progesterone receptor modulators with gene selective and context-dependent partial agonism. Biochem Pharmacol 2009, 77:204-215.
22. Lee A.C., Dai Z., Chen B., Wu H., Wang J., Zhang A., et al. Electrochemical branched-DNA assay for polymerase chain reaction-free detection and quantification of oncogenes in messenger rna. Anal Chem 2008, 80:9402-9410.
23. Canales R.D., Luo Y., Willey J.C., Austermiller B., Barbacioru C.C., Boysen C., et al. Evaluation of DNA microarray results with quantitative gene expression platforms. Nat Biotechnol 2006, 24:1115-1122.